IMAX Achieves Record $1.28 Billion Global Box Office in 2025
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 09 2026
0mins
Should l Buy IMAX?
Source: CNBC
- Box Office Growth: IMAX achieved a record global box office of $1.28 billion in 2025, representing over a 40% increase from 2024, not only setting a new high but also surpassing its previous record from 2019, showcasing its strong performance in the theatrical industry.
- Market Share Increase: In 2025, over 16% of domestic ticket sales came from premium large format theaters, up from 15% in 2024, indicating a growing consumer preference for high-quality viewing experiences, which IMAX is well-positioned to capitalize on.
- Strong Profitability: IMAX reported a net income of $43 million in the first three quarters of 2025, a 67% increase from the same period in 2024, demonstrating the advantages of its asset-light model that allows it to remain profitable in a competitive market.
- Optimistic Future Outlook: IMAX forecasts a new record global box office of $1.4 billion in 2026, bolstered by upcoming blockbuster releases such as
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy IMAX?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on IMAX
Wall Street analysts forecast IMAX stock price to rise
12 Analyst Rating
11 Buy
1 Hold
0 Sell
Strong Buy
Current: 39.190
Low
34.00
Averages
44.00
High
47.00
Current: 39.190
Low
34.00
Averages
44.00
High
47.00
About IMAX
Imax Corporation is a premier global technology platform for entertainment and events. Through its proprietary software, auditorium, architecture, patented intellectual property, and specialized equipment, the Company offers an end-to-end solution to create content experiences. The Company operates through two segments: Content Solutions and Technology Products and Services. The Content Solutions segment principally includes content enhancement and distribution services. This segment is also engaged in the distribution of large-format documentary films and exclusive experiences ranging from live performances to interactive events with artists and creators, as well as film post-production services. The Technology Products and Services principally include the sale, lease, and maintenance of IMAX Systems. This segment is also involved in ancillary theater business activities, including after-market sales of IMAX System parts and three-dimensional (3D) glasses.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Strong Cash Flow but Weak Returns: Company Analysis
- BrightView Challenges: BrightView (NYSE:BV), serving as an official field consultant for Major League Baseball, has seen a 1.8% annual sales decline over the past two years, leading to a 3.3% annual contraction in earnings per share, indicating management's struggles with effective fund allocation, which negatively impacts long-term returns.
- Stride's Strong Performance: Stride (NYSE:LRN) achieved an impressive 14.6% annual revenue growth over the past five years, reflecting market share gains, while earnings per share surged by 45% annually over the last two years, with management's effective investments driving rising returns on capital; currently trading at $84.36 with a forward P/E of 9.8x.
- IMAX Growth Potential: IMAX (NYSE:IMAX) has experienced a 24.5% annual revenue growth over the past five years, with free cash flow margin increasing by 24.3 percentage points, indicating that historical investments are beginning to pay off, currently priced at $37.85 with a forward P/E of 22.6x.
- Market Dynamics Observation: While BrightView faces market challenges, the strong performances of Stride and IMAX highlight investment opportunities in the education technology and cinema technology sectors, suggesting that investors should pay attention to these companies' growth potential moving forward.
See More
IMAX CEO Richard Gelfond Sells 121,220 Shares
- Transaction Overview: IMAX CEO Richard Gelfond sold 121,220 common shares on March 10, 2026, for approximately $4.86 million, reflecting his strategy to exercise options and sell shares during a market upswing.
- Historical Comparison: The sale of 121,220 shares exceeds Gelfond's median prior transactions of 100,000 shares, indicating a proactive approach under current market conditions, despite a decrease in direct holdings.
- Holding Analysis: While Gelfond's direct holdings decreased to 765,002 shares, he still retains significant exposure with 1,697,475 outstanding options and 231,562 restricted share units, maintaining a strong investment position in IMAX.
- Market Performance Impact: The weighted average sale price of approximately $40.10 per share was slightly above the market close of $39.71 on March 10, 2026, reflecting a total return of 58.09% over the past year, suggesting that shareholders may consider profit-taking amid expectations of strong future sales.
See More
IMAX CEO Richard Gelfond Sells 121,220 Shares for $4.86 Million
- Sale Details: IMAX CEO Richard Gelfond sold 121,220 common shares on March 10, 2026, for approximately $4.86 million at a weighted average price of around $40.10 per share, reflecting strong market performance for the company's stock.
- Shareholding Status: Post-transaction, Gelfond retains 765,002 common shares along with outstanding options and restricted share units, indicating his confidence in IMAX's future growth and continued investment in the company.
- Market Performance: IMAX achieved a record revenue of $410 million in 2025, marking a 16% year-over-year increase, and is expected to maintain strong sales in 2026, which has driven the stock price to a 52-week high of $43.16.
- Investment Advice: Despite the current price-to-earnings ratio of 60 indicating a high valuation, analysts suggest that investors should wait for a price drop before considering buying IMAX stock to enter at more favorable conditions.
See More
Paramount and Warner Bros. Merger Could Reshape Box Office Landscape
- Massive Merger Potential: The merger between Paramount and Warner Bros. has an enterprise value of $111 billion and aims to produce 30 films annually, with 15 from each studio, potentially resulting in a powerful slate of 26 films in 2027, significantly enhancing market competitiveness.
- Optimistic Box Office Outlook: Warner Bros.' high-budget films like 'The Batman' and 'Minecraft Movie' have performed exceptionally well at the global box office, with the former earning $772 million and the latter nearing $1 billion, laying a solid foundation for the combined box office performance and potentially making it the largest single studio in 2027.
- Intensified Market Competition: The merged entity will face fierce competition from Disney and Universal, which are also set to release strong franchises, and while the merger presents potential box office advantages, uncertainties remain, particularly regarding audience overlap.
- Distribution Strategy Challenges: The combined company plans to release 30 films over 52 weekends, necessitating precise distribution strategies to avoid cannibalizing ticket sales, especially with Paramount's 'Sonic the Hedgehog 4' scheduled just a week before Warner's 'Godzilla X Kong: Supernova', which may require adjustments to optimize revenue.
See More
IMAX Corp (IMAX.US) Officer Plans to Sell $4.81 Million in Common Stock via Form 144
- IMAX Officer's Stock Sale: IMAX Corporation officer Richard Gelfond plans to sell 121,222 shares of its common stock.
- Market Value of Sale: The total market value of the shares to be sold is approximately $4.81 million.
See More
IMAX CEO Discusses Oscars Season Buzz
- Oscars Season Involvement: IMAX CEO Richard Gelfond discussed the company's involvement in several nominated productions, showcasing IMAX's ongoing influence in the premium film market, which could enhance brand recognition and box office revenue.
- Market Prediction Insights: Gelfond's insights on market predictions and industry dynamics may provide valuable information for investors regarding IMAX's future performance, aiding strategic decision-making in the competitive entertainment sector.
- Program Interaction: In his conversation with Opening Bid host Brian Sozzito, Gelfond emphasized IMAX's efforts to enhance the viewing experience, further solidifying its leadership position in cinema technology.
- Audience Feedback: IMAX's involvement may attract more viewers to nominated productions, thereby boosting overall box office performance and reflecting the company's significant role in the film industry supply chain.
See More
Strong Cash Flow but Weak Returns: Company Analysis
- BrightView Challenges: BrightView (NYSE:BV), serving as an official field consultant for Major League Baseball, has seen a 1.8% annual sales decline over the past two years, leading to a 3.3% annual contraction in earnings per share, indicating management's struggles with effective fund allocation, which negatively impacts long-term returns.
- Stride's Strong Performance: Stride (NYSE:LRN) achieved an impressive 14.6% annual revenue growth over the past five years, reflecting market share gains, while earnings per share surged by 45% annually over the last two years, with management's effective investments driving rising returns on capital; currently trading at $84.36 with a forward P/E of 9.8x.
- IMAX Growth Potential: IMAX (NYSE:IMAX) has experienced a 24.5% annual revenue growth over the past five years, with free cash flow margin increasing by 24.3 percentage points, indicating that historical investments are beginning to pay off, currently priced at $37.85 with a forward P/E of 22.6x.
- Market Dynamics Observation: While BrightView faces market challenges, the strong performances of Stride and IMAX highlight investment opportunities in the education technology and cinema technology sectors, suggesting that investors should pay attention to these companies' growth potential moving forward.
See More
IMAX CEO Richard Gelfond Sells 121,220 Shares
- Transaction Overview: IMAX CEO Richard Gelfond sold 121,220 common shares on March 10, 2026, for approximately $4.86 million, reflecting his strategy to exercise options and sell shares during a market upswing.
- Historical Comparison: The sale of 121,220 shares exceeds Gelfond's median prior transactions of 100,000 shares, indicating a proactive approach under current market conditions, despite a decrease in direct holdings.
- Holding Analysis: While Gelfond's direct holdings decreased to 765,002 shares, he still retains significant exposure with 1,697,475 outstanding options and 231,562 restricted share units, maintaining a strong investment position in IMAX.
- Market Performance Impact: The weighted average sale price of approximately $40.10 per share was slightly above the market close of $39.71 on March 10, 2026, reflecting a total return of 58.09% over the past year, suggesting that shareholders may consider profit-taking amid expectations of strong future sales.
See More
IMAX CEO Richard Gelfond Sells 121,220 Shares for $4.86 Million
- Sale Details: IMAX CEO Richard Gelfond sold 121,220 common shares on March 10, 2026, for approximately $4.86 million at a weighted average price of around $40.10 per share, reflecting strong market performance for the company's stock.
- Shareholding Status: Post-transaction, Gelfond retains 765,002 common shares along with outstanding options and restricted share units, indicating his confidence in IMAX's future growth and continued investment in the company.
- Market Performance: IMAX achieved a record revenue of $410 million in 2025, marking a 16% year-over-year increase, and is expected to maintain strong sales in 2026, which has driven the stock price to a 52-week high of $43.16.
- Investment Advice: Despite the current price-to-earnings ratio of 60 indicating a high valuation, analysts suggest that investors should wait for a price drop before considering buying IMAX stock to enter at more favorable conditions.
See More
Paramount and Warner Bros. Merger Could Reshape Box Office Landscape
- Massive Merger Potential: The merger between Paramount and Warner Bros. has an enterprise value of $111 billion and aims to produce 30 films annually, with 15 from each studio, potentially resulting in a powerful slate of 26 films in 2027, significantly enhancing market competitiveness.
- Optimistic Box Office Outlook: Warner Bros.' high-budget films like 'The Batman' and 'Minecraft Movie' have performed exceptionally well at the global box office, with the former earning $772 million and the latter nearing $1 billion, laying a solid foundation for the combined box office performance and potentially making it the largest single studio in 2027.
- Intensified Market Competition: The merged entity will face fierce competition from Disney and Universal, which are also set to release strong franchises, and while the merger presents potential box office advantages, uncertainties remain, particularly regarding audience overlap.
- Distribution Strategy Challenges: The combined company plans to release 30 films over 52 weekends, necessitating precise distribution strategies to avoid cannibalizing ticket sales, especially with Paramount's 'Sonic the Hedgehog 4' scheduled just a week before Warner's 'Godzilla X Kong: Supernova', which may require adjustments to optimize revenue.
See More
IMAX Corp (IMAX.US) Officer Plans to Sell $4.81 Million in Common Stock via Form 144
- IMAX Officer's Stock Sale: IMAX Corporation officer Richard Gelfond plans to sell 121,222 shares of its common stock.
- Market Value of Sale: The total market value of the shares to be sold is approximately $4.81 million.
See More
IMAX CEO Discusses Oscars Season Buzz
- Oscars Season Involvement: IMAX CEO Richard Gelfond discussed the company's involvement in several nominated productions, showcasing IMAX's ongoing influence in the premium film market, which could enhance brand recognition and box office revenue.
- Market Prediction Insights: Gelfond's insights on market predictions and industry dynamics may provide valuable information for investors regarding IMAX's future performance, aiding strategic decision-making in the competitive entertainment sector.
- Program Interaction: In his conversation with Opening Bid host Brian Sozzito, Gelfond emphasized IMAX's efforts to enhance the viewing experience, further solidifying its leadership position in cinema technology.
- Audience Feedback: IMAX's involvement may attract more viewers to nominated productions, thereby boosting overall box office performance and reflecting the company's significant role in the film industry supply chain.
See More
